May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Effects of the Fusion Protein PTD4–Profilin I on Trabecular Meshwork Cells and Outflow Facility
Author Affiliations & Notes
  • X. Gasull
    Lab. Neurofisiologia, Facultat de Medicina–IDIBAPS, University of Barcelona, Barcelona, Spain
  • A. Gomez–Cabrero
    Lab. Neurofisiologia, Facultat de Medicina–IDIBAPS, University of Barcelona, Barcelona, Spain
  • N. Comes
    Lab. Neurofisiologia, Facultat de Medicina–IDIBAPS, University of Barcelona, Barcelona, Spain
  • J. Pales
    Lab. Neurofisiologia, Facultat de Medicina–IDIBAPS, University of Barcelona, Barcelona, Spain
  • A. Gual
    Lab. Neurofisiologia, Facultat de Medicina–IDIBAPS, University of Barcelona, Barcelona, Spain
  • M. Morales
    Lab. Neurofisiologia, Facultat de Medicina–IDIBAPS, University of Barcelona, Barcelona, Spain
  • Footnotes
    Commercial Relationships  X. Gasull, None; A. Gomez–Cabrero, None; N. Comes, None; J. Pales, None; A. Gual, None; M. Morales, None.
  • Footnotes
    Support  SAFV2002–PN–03517–O, BFI2003–1190, FIS 031495
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 3703. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      X. Gasull, A. Gomez–Cabrero, N. Comes, J. Pales, A. Gual, M. Morales; Effects of the Fusion Protein PTD4–Profilin I on Trabecular Meshwork Cells and Outflow Facility . Invest. Ophthalmol. Vis. Sci. 2005;46(13):3703.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Fusion proteins with a protein transduction domain (PTD) are able to cross biological membranes. This technology has been used successfully in a wide variety of cells to introduce proteins, DNA, liposomes and drugs. We have evaluated a PTD4–Profilin I construct in trabecular meshwork (TM) cells and trabecular outflow facility. Profilin I is a nucleotid exchange protein that binds monomeric actin and regulates actin polimerization. Since previous studies have shown that latrunculin A increases aqueous humor (AH) outflow, we have studied the regulation of actin cytoskeleton on TM cells and outflow facility. Methods: pRSETA–m–Profilin I (control) and pRSETA–PTD4–Profilin I constructs were created and expressed in bacteria. Purified proteins were detected by western blotting and tested by immunocytochemistry in bovine TM primary cultures. Outflow facility studies were performed in bovine anterior segments perfused at constant pressure. Results: Western blot revealed two proteins of 20 and 25 KDa corresponding to Profilin I and PTD4–Profilin I. Immunocytochemistry showed a time and concentration–dependent transduction of PTD4–Profilin I (10–120min; 1–10µM) in TM cells. Confocal microscopy confirmed the protein presence in the cell cytoplasm that was not seen when control Profilin I was used. Actin filament staining showed that the effects of PTD4–Profilin I in the actin cytoskeleton were weaker compared with latrunculin A. In perfused anterior segments, 2µM PTD4–Profilin I significantly increased trabecular outflow facility in a reversible manner while control Profilin I did not induce any effect. Latrunculin A (2µM), as a positive control, also increased outflow facility significantly. Conclusions: This work proves the applicability of protein transduction technology to TM tissue, as a tool to study its physiology and a possible drug–delivery method. Moreover, results indicate that regulation of actin cytoskeleton by Profilin I or other actin binding proteins may be a physiological mechanism to modulate AH outflow.

Keywords: trabecular meshwork • cytoskeleton • protein purification and characterization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×